A special Mini-Meet of the Working Group on Public-Private Mix for TB Prevention and Care (PPM Working Group) will be held virtually on 20 May 2021 in an interactive format. The meeting is open to all participants.

TAG and AfroCAB are inviting applications from treatment activists and community leaders for a new cross-disease long-acting technologies community advisory board. The deadline to apply is 21 May 2021.

The Tuberculosis Vaccine Initiative (TBVI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) developed several new tools to support future TB vaccine clinical trials: templates and guidelines to support preparations for a regulatory plan, a data management plan and clinical trial protocol synopses, and a comprehensive registry of trial sites in sub-Saharan Africa.

High rates of tuberculosis (TB) in Latin American prisons are subverting efforts to control the disease in the wider population, and constitute a “health and human rights crisis”, a study warns.

Treatment Action Group (TAG) is seeking a consultant to advance strategic policy-advocacy and resource mobilization efforts for TB research and development (R&D) in the context of the European Union (EU) and UK global development cooperation.

RESIST-TB released its April 2021 newsletter with the latest research publications on drug-resistant TB.

On 20 April 2021, the TB Europe Coalition and the Regional Expert Group on Migration and Health in Eastern Europe and Central Asia co-hosted a webinar addressing the barriers migrants face when accessing TB and healthcare services across the Western European countries and the challenges for service delivery.

Urgent actions to stop preventable deaths and suffering due to TB and recover gains lost during the COVID-19 pandemic.

South Africa’s First National TB Prevalence Survey (findings of which were published earlier this year) found that in 2018, the country’s tuberculosis burden was substantially higher than previously thought.